THE LATEST NEWS IN CANCER CLINICAL RESEARCH

Phergain Collaborators’ Ecosystem in Spain.

Advancing Oncology Care: MEDSIR at ASCO Annual Meeting

MEDSIR at ASCO 2023

Revolutionizing Patient Care: MEDSIR's Hope for HER2-Positive Early Breast Cancer

Strategic partnership between MEDSIR and REVEAL GENOMICS® for cancer research

Spotlight - LINGain biomarker study

We enjoyed presenting our work at ESMO BREAST 2022

We’re presenting at ESMO Breast Cancer 2022!

WHAT A 2021 WE HAD!

Spotlight: PHERGain-2 HER2+ early breast cancer trial

Dr. José Manuel Pérez Discusses Advances in Treatment Options for HER2+ Breast Cancer

Chemotherapy de-escalation: outstanding advances in the treatment of breast cancer

PHERGain Study (breast)